FGF2 and neoplasm: The results indicated that the ds-Diabody could effectively neutralize the paracrine and autocrine bFGF in tumors and block the signaling pathways of MAPK/ERK and PI3K/AKT and inhibit the tumor angiogenesis and lymphangiogenesis.